If this message displays incorrectly, please view the web page |
||||||||||||||||
|
||||||||||||||||
GLOBAL HEALTH |
||||||||||||||||
HEMATOLOGY/ONCOLOGY/TRANSPLANTATION Clinical trial uses patients' cells to fight complications of bone marrow transplant A clinical trial using personalized cell therapy is designed to help reduce graft-versus-host disease, a life-threatening complication of bone marrow transplantation (BMT) in which donor immune lymphocytes attack the organs of the transplant recipient. BMT is used to treat some patients with leukemia and other blood and bone marrow disorders. Read more... |
||||||||||||||||
INFECTIOUS DISEASES Measles causes long-lasting effects of "immune amnesia" The measles virus can suppress the immune systems of children for up to three years, wiping out already existing immunity and leaving children highly susceptible to a host of other diseases. Researchers say their findings show the measles vaccine has benefits that extend beyond protection against the measles virus itself. Read more... |
||||||||||||||||
CANCER New Molecular Approach Promotes Death of Lung Cancer Cells A new compound helps promote the death of cancer cells in the laboratory by inhibiting a protein called Bcl-2. The potential drug could provide a new weapon against lung cancer by converting Bcl-2 from its normal role in protecting cancer cells to one of promoting apoptosis, or death of cancer cells. Researchers soon hope to test the drug in eligible patients. Read more... |
||||||||||||||||
Link to current issue | Archives | More Research News | Contact Us |
||||||||||||||||
Editor, Holly Korschun, Executive Director of Research Communications |
||||||||||||||||